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Rationale: Small airways constitute a major site of pathology in cystic
fibrosis (CF) and provide most of the surface area of the conducting
airways of the lung. Little is known, however, about the impact of
CF on ion and fluid transport in small (bronchiolar) airways.
Objectives: To describe the ion and fluid transport properties of CF
bronchiolar epithelium.
Methods: Primary cultures of human bronchial and bronchiolar
(non-CF and CF) epithelial cells were obtained. The bioelectric prop-
erties were studied in Ussing chambers and the airway surface liquid
(ASL) height was measured with confocal microscopy.
Main Results: Primary cultures of F508 CF bronchiolar epithelial cells
displayed higher transepithelial resistance than non-CF cultures,
whereas baseline short circuit current and amiloride-inhibitable
short circuit current were similar in both preparations. The ASL
height was significantly smaller in CF compared with non-CF prepa-
rations. In the presence of amiloride, addition of forskolin increased
short circuit current in non-CF but not in CF bronchiolar cultures,
and the ATP-induced increase in short circuit current was lower
in CF than in non-CF cultures. Non-CF bronchiolar preparations
displayed larger short circuit current and fluid secretion in responses
to forskolin than non-CF bronchial preparations, suggesting that
CFTR-dependent Cl transport may play a more important role
in the regulation of fluid transport in small airways than in large
airways.
Conclusion: In CF small airways, defective Cl secretion combined with
unregulated (persistent) Na absorption results in ASLdepletion.
Keywords: airway surface liquid; bronchiole; cystic fibrosis transmem-
brane conductance regulator; human; ion transport
Airway epithelial ion transport processes play a major role in
the regulation of the volume and composition of the airway
surface liquid (ASL) by generating osmotic gradients that pro-
vide a driving force for transepithelial fluid movement. The dom-
inant basal ion transport in large airways is active amiloride-
sensitive Na absorption that induces passive Cl and water
absorption (1). When Na absorption is inhibited, active trans-
epithelial Cl secretion can be stimulated by agents that increase
intracellular cAMP or Ca2 concentrations and may reverse the
direction of liquid transport toward secretion. The airway epithe-
lium is capable of fine regulation of the ASL volume (1). The
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crucial role of airway epithelial ion transport is illustrated by
cystic fibrosis (CF), a lethal genetic disorder that results from
mutations in the cystic fibrosis transmembrane conductance reg-
ulator (CFTR) gene. CFTR exerts many functions in the airway
epithelium and, in particular, acts as a cAMP-activated Cl chan-
nel and as a regulator of other ion channels, such as the epithelial
Na channel (ENaC) (2, 3). In CF large airways, epithelial ion
and fluid transport abnormalities include unregulated amiloride-
sensitive Na absorption and impaired Cl secretion (4, 5) that
lead to ASL depletion, which promotes mucus adhesion and
chronic bacterial colonization (6, 7).
Although small airways account for the largest portion of the
total surface area of the airways and are a major site of pathology
in various diseases, such as asthma, chronic bronchitis, and CF,
characterization of the epithelial functions of small airways has
been limited by their relative inaccessibility. Small airways share
many anatomic, histologic, and physiologic features with large
airways but there are also distinct regional differences. For
instance, small airways do not possess submucosal glands and
cartilaginous rings, and the cell populations in the mucosa are
not entirely similar in large and small airways: Clara cells are
absent in large airways, and basal cells, which constitute approxi-
mately 30% of the total cell number in human bronchi, are
absent in bronchioles (8, 9).
In young children, CF is primarily a disease of small airways.
Pathologic studies of the lungs of young children with CF reveal
small airways characterized by mucus obstruction, decreased
number (density), and bronchiolectasis (10–16). Examination of
the bronchoalveolar lavage fluid in children with CF suggests
inflammation in the distal regions of the lung (17, 18). Lung
function studies demonstrate airway obstruction that affects dis-
tal airways more severely than proximal airways (19, 20). Be-
cause abnormalities in large airway epithelial ion transport are
implicated in the CF lung disease, ion transport in CF small
airways is also likely abnormal. We have previously reported
that non-CF human bronchioles actively absorb Na and fluid
in the basal state and are capable of active Cl and fluid secretion
when exposed to agents that increase intracellular cAMP and
Ca2 concentrations (21). Here, we investigated the epithelial
ion and fluid transport properties of CF small airways. We hy-
pothesized that epithelial ion transport in CF small airways paral-
lels that of large airways. These findings could have implications
in the design of therapies aimed at correcting ion and fluid
transport abnormalities in CF lung disease. Some of the results
have been previously reported in the form of abstracts (22, 23).
METHODS
Details are provided in the online supplement.
Cell Isolation and Culture
Lung fragments were obtained from 12 non-CF patients who underwent
surgery for lung cancer (61.7  2.9 yr), from 16 healthy lung transplant
donors (46.6  4 yr), and from 9 F508 homozygous patients with CF
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(25.5  3.4 yr) who underwent lung transplantation. Procedures were
performed in compliance with the French legislation and the Institu-
tional Review Board for the Protection of Human Rights at the Univer-
sity of North Carolina. Human non-CF and CF bronchi were identified
on the basis of an outer diameter of 3 to 10 mm and the presence of
cartilage. Non-CF bronchioles were identified by the absence of carti-
lage and an outer diameter  1 mm. Because CF bronchioles exhibit
bronchiectasis with increased airway diameter (13), they were selected
on the basis of absence of cartilage and proximity to the pleura ( 1 cm).
Bronchial and bronchiolar epithelial cells were isolated and cultured on
collagen matrix support in air–liquid interface as previously described
(21). For confocal microscopy studies, cells were cultured on Transwell-Col
porous filters (Costar, New York, NY) as previously described (24, 25).
Histologic Studies
Preparations were embedded in paraffin and processed for standard
hematoxylin and eosin staining and for immunocytochemistry.
Ussing Chamber Studies
Confluent cultures on collagen matrix support were mounted in Ussing
chambers. The short-circuit current (Isc), the potential difference (PD),
and the transepithelial resistance (Rt) were measured under baseline
conditions and the effects of successive additions of amiloride, forskolin,
and ATP were studied as previously described (21).
Confocal Microscopy Measurement of ASL Height
The measurement of ASL height was performed as previously described
(7). The heights of ASL were measured using a laser scanning inverted
confocal microscope (Leica Microsystems, Inc., Exton, PA), at baseline
(t0 h) and at t2 h, t6 h, and t24 h after addition of 20 l phosphate-
buffered saline (PBS) containing Texas red–dextran (2 mg/ml).
To evaluate the effect of forskolin on ASL height in non-CF bron-
chial and bronchiolar cultures, Texas red–dextran in PBS was delivered
to the apical surface of the preparations and measurements performed
on the following day after stabilization of ASL height. After measure-
ment of the initial ASL height, the cultures were exposed to amiloride
(apical side), forskolin (basolateral side), or vehicles. ASL height mea-
surements were performed before (t0 h) and 1, 2, and 24 h after the
addition of the drugs. To assess recovery, ASL height was also measured
24 h after removal of the drugs (t48 h). Also studied were the effect
of amiloride alone in some non-CF bronchiolar preparations at t0 h
and t2 h.
Statistical Analysis
Values are expressed as mean  SEM. Comparisons between non-CF
and CF data were made using the unpaired Student t test. To compare
the bioelectric properties of large and small airway cultures from the
same patient, we used the mean of one to four bronchial cultures and
one or two bronchiolar cultures for each patient, and the paired Student
t test. Comparison between ASL heights in bronchial and bronchiolar
non-CF cultures were performed with the Proc-mixed code for repeated
measurement (SAS/STAT software version 8.0; SAS, Gregy-sur-Yerres,
France). A p  0.05 was considered as significant.
RESULTS
Histologic Studies
The cell preparations used for immunohistochemical studies
were first tested in Ussing chambers to ensure that they had
developed active transepithelial ion transport. Primary cultures
of non-CF and CF bronchiolar epithelial cells, and of non-CF
bronchial epithelial cells, were well-differentiated and exhibited
typical ciliated cells (which represented the predominant cell
type) and nonciliated cuboidal granular cells (Figure 1). Immuno-
reactivity for human cytokeratins was detected in all cells (Figure
1). Light microscopic examination revealed no significant differ-
ence between non-CF and CF bronchiolar cultures. In the com-
parison of non-CF cultures from different airway regions, bron-
chial cultures typically displayed two to three cell layers and an
average height of 32.4  4.1 m (n 	 5), whereas bronchiolar
cultures usually exhibited one or two cell layers and an average
height of 19.1  2.5 m (n 	 6, p  0.02).
Ussing Chamber Studies of CF and Non-CF Bronchi
The bioelectric properties of six bronchial epithelial cell cultures
obtained from F508 homozygous patients with CF were mea-
sured in Ussing chambers and compared with the bioelectric
properties of 18 non-CF bronchial epithelial cell cultures. The
basal PD, Isc, and Rt of CF cultures were 3.8  0.7 mV, 65.4 
15 A/cm2, and 68.8  16.7 
.cm2 versus 2  0.3 mV, 29 
4.5 A/cm2, and 86.2  12.9 
.cm2 for the non-CF cultures.
Changes in Isc induced by amiloride, forskolin, and ATP in CF
cultures were 53.2  14.5, 0.1  0.2, and 25  7.1 A/cm2,
respectively (vs. 12.9  3.3, 1.6  0.4, and 17.4  5.2 A/cm2).
The baseline PD, Isc, and the amiloride-induced decrease in Isc
were significantly higher in CF than in non-CF bronchial cultures
(p  0.05 for all). In contrast, the forskolin effect on Isc in CF
cultures was not significant and was significantly lower than in
non-CF bronchial cultures (p  0.05).
Ussing Chamber Studies of CF and Non-CF Bronchioles
The bioelectric properties of 20 bronchiolar epithelial cultures
obtained from non-CF subjects and 27 bronchiolar epithelial cell
cultures obtained from F508 homozygous patients with CF
were measured in Ussing chambers. The basal bioelectric proper-
ties of the non-CF and CF cultures are shown in Table 1. The
baseline PD and Rt were significantly higher in CF than in non-
CF bronchiolar cultures. In contrast, the baseline Isc was not
significantly different between non-CF and CF preparations.
Addition of the Na channel blocker amiloride to the apical
bath significantly reduced Isc in non-CF and CF bronchiolar cul-
tures but the amiloride-induced decrease of Isc was not signifi-
cantly different in non-CF and CF preparations (Figure 2). The
residual Isc in non-CF and CF bronchiolar cultures was different,
however, 16.6  2.1 and 10.3  1.8 A/cm2, respectively (p 
0.05). In the presence of amiloride, exposure to forskolin signifi-
cantly increased Isc in non-CF cultures, whereas no response
was detected in CF cultures. In the presence of amiloride and
forskolin, the addition of ATP further increased Isc in non-CF
and CF bronchiolar cultures. The ATP-induced increase in Isc,
however, was significantly lower in CF than in non-CF cultures
(Figure 2).
In non-CF bronchiolar preparations, the addition of the
CFTR inhibitor DPC to the apical solution significantly de-
creased the Isc in the presence of amiloride (15.4  1.4 [n 	 8]
vs. 2.8  0.9 A/cm2 for vehicle [n 	 6]; p  0.05). The
forskolin-induced increase in Isc was also significantly lower in
the presence of amiloride and diphenylamine-2,2-dicarboxylic
acid (DPC) than in the presence of amiloride and the DPC
vehicle (0.9  0.3 vs. 3.7  0.5 A/cm2, p  0.05).
Ussing Chamber Studies of Non-CF Bronchi and Bronchioles
To compare the effect of forskolin in bronchial and bronchiolar
epithelia, we used cell cultures obtained from the same patients
to minimize interindividual variability. Eighteen cultures of
bronchial epithelial cells and 12 cultures of bronchiolar epithelial
cells were obtained from 10 non-CF patients (age, 61.4  3.5 yr).
The basal bioelectric properties of these bronchial and bronchio-
lar cultures are shown in Table 2. When compared with bronchial
preparations, the baseline PD and Rt of bronchiolar epithelial
cell cultures were significantly lower, whereas the baseline Isc
was similar (Table 2). The amiloride-induced decreases in Isc and
the ATP-activated increases in Isc were not significantly different
in bronchial and bronchiolar preparations (Figure 3). In contrast,
the forskolin-induced increases in Isc were significantly larger in
bronchiolar than in bronchial cultures (Figure 3; p  0.05).
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Figure 1. Histologic sections of
two representative primary cul-
tures of cystic fibrosis (CF) (A and
D) and non-CF (B and E ) bron-
chiolar epithelial cells, and of
non-CF bronchial epithelial cells
(C and F). Three-micrometer-
thick sections of cultured epi-
thelial cells were stained with
hematoxylin and eosin (A, B,
and C ) (scale bars: 10 m). The
corresponding immunostain-
ing with anti–CKAE1-AE3 anti-
bodies confirmed the epithelial
nature of the cultures (D, E, and
F ) (scale bars: 10 m).
Confocal Microscopy Measurement of ASL Height
The effect of a volume challenge on ASL volume homeostasis
was studied on bronchiolar epithelial cell cultures obtained from
11 non-CF patients (mean age, 46.1  5.0 yr) and from 4 F508
homozygous patients with CF (mean age, 28.7  6.0 yr). Results
are shown in Figure 4A. The initial ASL height after addition
of excess periciliary liquid layer (PCL) was 26.3  1.8 m in non-
CF preparations (n 	 22) and 28.3  2 m in CF preparations
(n 	 11, not significant). Both culture types displayed a rapid
absorption of ASL during the first 12 h, but the ASL height
decreased more rapidly in CF than in non-CF preparations (CF:
t2 h: 5.7  1.3 m, t6 h: 3.5  0.5 m vs. non-CF: t2 h: 12.1 
1.4 m, t6 h: 8.1  1.2 m; p  0.05). Between t6 h and t24 h,
the ASL heights were stable in both preparations and significantly
smaller in CF (t24 h: 3.7  0.4 m for CF vs. 8  0.9 m for
non-CF; p  0.05).
TABLE 1. BIOELECTRIC PROPERTIES OF CULTURED HUMAN
NON-CYSTIC FIBROSIS AND CYSTIC FIBROSIS
BRONCHIOLAR EPITHELIAL CELLS
PD (mV) Isc (A/cm2) Rt (
. cm2)
Non-CF bronchiolar cultures (n 	 20) 1.1  0.2 34.2  6.1 36.4  3.6
CF bronchiolar cultures (n 	 27) 2.1  0.3* 29.0  3.6 84.3  8.5*
Definition of abbreviations: CF 	 cystic fibrosis; PD 	 potential difference.
The transepithelial PD, the equivalent short circuit current (Isc), and the transepi-
thelial resistance (Rt) were measured.
* Statistically significant difference between non-CF and CF bronchiolar prepara-
tions (p  0.05).
To study the effect of forskolin on ASL height in non-CF
bronchial and bronchiolar preparations, cultures were obtained
from lungs resected from seven patients (mean age, 51.4 
6.9 yr). In control experiments, there was no significant change
in ASL height measured at t0 h, t1 h, t2 h, and t24 h in non-CF
bronchial (t0 h: 7.1  0.3 m, t1 h: 7.2  0.4 m, t2 h: 7.6 
0.5 m and t24 h: 7.8  0.4 m; n 	 10) and bronchiolar (t0 h:
6.4  0.5 m, t1 h: 6.7  0.6 m, t2 h: 6.4  0.6 m and
t24 h: 7.1  0.4 m; n 	 11) cultures, suggesting that repeated
measurements had no impact on ASL height. The ASL heights
Figure 2. Changes in Isc induced by sequential addition of amiloride,
forskolin, and ATP in primary cultures of non-CF (white bars, n 	 20
preparations from 16 patients) and CF (black bars, n 	 27 preparations
from four patients) bronchiolar epithelial cells. *Statistically significant
difference (p  0.05).
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TABLE 2. BIOELECTRIC PROPERTIES OF CULTURED HUMAN BRONCHIAL AND BRONCHIOLAR
EPITHELIAL CELLS FROM THE SAME PATIENTS
Baseline Amiloride Forskolin ATP
PD (mV) Isc (A/cm2) Rt (
. cm2) Isc (A/cm2) Isc (A/cm2) Isc (A/cm2)
Bronchial cultures (n 	 18) 2.0  0.3 29.0  4.5 86.2  12.9 12.9  3.3 1.6  0.4 17.4  5.2
Bronchiolar cultures (n 	 12) 1.0  0.2* 32.1  4.3 32.3  4.2* 15.1  4.2 4.4  0.9* 22.9  3.1
For definition of abbreviations, see Table 1.
Primary cultures of human bronchial and bronchiolar epithelial cells were obtained from 10 non-CF patients and studied in
Ussing-type chambers. The transepithelial PD, the equivalent short circuit current (Isc), and the transepithelial resistance (Rt) were
measured. Amiloride, forskolin, and ATP were added sequentially.
* Statistically significant difference between bronchial and bronchiolar preparations (p  0.05).
measured before (t0 h) and after (t1 h, t2 h, and t24 h) addition
of forskolin and amiloride in bronchial and bronchiolar prepara-
tions are displayed in Figure 4B. In the presence of amiloride,
the response to forskolin was significantly greater in bronchioles
than in bronchi (p  0.05). At t2 h, the ASL height had increased
by approximately 4 m in bronchial cultures, and by approxi-
mately 6 m on bronchiolar cultures when compared with t0 h,
corresponding to a calculated fluid secretion of approximately
0.4 and 0.6 l/cm2 on bronchial and bronchiolar cultures, respec-
tively. At t48 h, the ASL heights in bronchial and bronchiolar
cultures were not different from their values at t0 h (5.4  0.2
and 5.8  1.8 m, respectively).
To evaluate the effect of amiloride alone on ASL homeosta-
sis, the ASL height was measured in the presence of amiloride,
amiloride plus forskolin, or vehicle in non-CF bronchiolar prepa-
rations. The results are displayed in Figure 5. At t0 h, the ASL
height was 6.3  0.5 m (n 	 9) in the amiloride group; 6.2 
0.3 m in the amiloride plus forskolin group (n 	 17); and
6.4  0.5 m (n 	 11) in the vehicle group (NS). At t2 h, the
ASL height was 8.6  0.7 m in the amiloride group; 12.9 
1.5 m for the amiloride plus forskolin group (p  0.05 compared
with amiloride alone); and 6.4  0.6 m in the vehicle group
(p  0.05 compared with amiloride alone and with amiloride
plus forskolin).
DISCUSSION
The main objective of this study was to compare the ion and
fluid transport properties of primary cultures of human non-
CF and homozygous F508 CF bronchiolar epithelial cells. We
obtained primary cultures of bronchial and bronchiolar epithelial
cells using standard procedures (21, 26). Histologic sections of
Figure 3. Changes in Isc induced by sequential addition of amiloride,
forskolin, and ATP in primary cultures of non-CF bronchial (gray bars,
n 	 18 cultures) and non-CF bronchiolar epithelial cells (white bars,
n 	 12) from the same 10 patients. *Statistically significant difference
(p  0.05).
non-CF and CF bronchiolar epithelial cultures revealed that
both were well differentiated and exhibited many of the features
of small airway epithelium in vivo, including a predominance of
ciliated cells. In addition, we observed no morphologic differ-
ences between CF and non-CF preparations. These findings are
consistent with previous studies on primary cultures of non-CF
and CF human epithelial cells from large airways (27). Non-CF
and CF airway epithelial preparations were submitted to the
Figure 4. (A ) Change in airway surface liquid (ASL) height in non-CF
bronchiolar (white circles, n 	 22 preparations from eight patients) and
in CF bronchiolar (black circles, n 	 11 preparations from four patients)
epithelial cell cultures exposed to an excess of liquid on the apical side.
Measurements were performed at t0 h, t2 h, t6 h, and t24 h. (B ) Change
in ASL height in non-CF bronchial (white squares, n 	 14 preparations)
and bronchiolar (white circles, n 	 17 preparations) cultures obtained
from the same eight patients and exposed to forskolin in the presence
of amiloride. Measurements were performed at t0 h, t1 h, t2 h, and
t24 h. At t24 h, the drugs were removed and an additional measurement
was performed at t48 h.
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Figure 5. Measurements of the height of the ASL in non-CF bronchiolar
cultures exposed during 2 h to amiloride alone and to amiloride 
forskolin. ASL height measurements were performed at t0 h (white bars)
and after 2 h (black bars) of exposure to vehicle (n 	 11), amiloride
(n 	 9), and amiloride  forskolin (n 	 17). *p  0.05 compared with
the vehicle group; §p  0.05 compared with the amiloride group.
same cell culture procedures, except that during the first 48 h
after seeding ceftazidime and tobramycin were present in the
culture medium of CF preparations. This addition is unlikely to
have affected our results because the bioelectric measurements
were performed 4 to 12 d after seeding. In addition, Randell
and coworkers have demonstrated that ceftazidime and tobra-
mycin do not affect the electrophysiologic properties of non-CF
and CF airway epithelial primary cultures (28). We also com-
pared non-CF bronchial and bronchiolar cultures histology and
found that the only apparent difference was the thickness of the
primary cultures, which mimics the in vivo situation (29).
We previously demonstrated that normal human bronchioles
actively absorb Na and fluid in unstimulated conditions and
are capable of active Cl and fluid secretion when exposed to
forskolin and ATP in the presence of amiloride (21). In the
present study, we compared the bioelectric properties of non-
CF and CF bronchiolar epithelial cells in primary culture. In
the basal state, the PD was twofold higher in CF than non-CF
bronchiolar preparations. This increase in PD resulted from an
increase in Rt in CF compared with non-CF cultures. An increase
in transcellular electrical resistance could account at least in part
for the increased Rt because we observed a defective forskolin-
and ATP-stimulated Cl secretion with no indication of a higher
Na absorption in CF compared with non-CF preparations. In-
creased paracellular resistance could also account for the in-
creased Rt. Willumsen and coworkers (30) calculated the paracel-
lular resistance in primary cultures of human nasal epithelial
non-CF and CF cells and found that it was slightly higher in CF
than in non-CF epithelia. A higher paracellular resistance in the
bronchiolar CF preparations cannot be ruled out even though
there was no histologic difference between non-CF and CF prep-
arations on microscopic examination, in particular the number
of cell layers and the height of the epithelium.
Human airway epithelial cells express ENaC and pumps (Na/
K-ATPase) to mediate transcellular Na absorption (5). Numer-
ous Ussing chamber studies and the present data have demon-
strated that CF nasal and large airway epithelia exhibit a twofold
to threefold increase in baseline Isc and that this increase can be
attributed to an accelerated amiloride-sensitive Na absorption
through ENaC channels located in the apical membrane of the
epithelial cells (5, 27, 31–33). We found no indication, however,
of an accelerated rate of Na absorption in CF bronchiolar
preparations. This result was unexpected, because non-CF small
airways displayed Na transport capacities similar to those ob-
served in non-CF bronchi (i.e., non-CF small airways exhibit
amiloride-sensitive Na absorption, which accounts for approxi-
mately 50% of the baseline Isc in Ussing chamber studies) (21).
Our experiments in non-CF bronchial and bronchiolar prepa-
rations from the same patients confirmed that the effect of ami-
loride on the baseline Isc was similar for both culture types and
consistent with previous reports in excised human non-CF bron-
chi and cultured human bronchial epithelial cells (34, 35). Animal
studies have also reported similar effects of amiloride on Isc in
bronchial and bronchiolar preparations (36, 37). There seems
to be a discrepancy in the magnitude of amiloride-sensitive Na
transport between bronchi and bronchioles in CF tissues. ENaC
and CFTR are expressed in both bronchial and bronchiolar
epithelial cells (38, 39). It is conceivable that the transporters
involved in the transepithelial absorption of Na and particularly
ENaC may not be regulated in the same way by CFTR in small
and large airways. Indeed, the effect of CFTR on ENaC differs in
various epithelia: CFTR downregulates ENaC activity in human
large airways (5) and colon (40); in contrast, activation of CFTR
Cl channel is accompanied by a concomitant activation of
ENaC in human sweat duct (41). This indicates that CFTR-
ENaC interactions are tissue specific and may be different in
large and small airways.
Our results obtained in vitro on cell cultures may be different,
however, from the in vivo situation. Indeed, our experimental
conditions (i.e., Ussing chambers) expose the epithelial surface
to a large volume of liquid and obviously do not represent the
actual in vivo situations (i.e., it assesses the capacities of the
epithelial layer to secrete and absorb ions). Recently, Tarran
and coworkers demonstrated that, under conditions that are
closer to the in vivo situation (primary cell cultures exposed
to air on their mucosal surface during measurements), normal
bronchial epithelia coordinate active absorptive and secretory
ion flows to control finely the quantity of salt on airway surfaces
and, hence, the ASL volume (42): when the ASL volume ap-
proaches an optimal depth (approximately 7 m), Na absorp-
tion is inhibited and the dominant ion transport turns to CFTR-
dependent Cl secretion. In CF bronchial preparations, Tarran
and coworkers (42) observed that Na absorption is not inhibited
(i.e., unregulated) because of the absence of the tonic inhibitory
influence of CFTR on the epithelial Na channel. This defect,
plus the absence of CFTR-dependent Cl secretion, results in
a reduced ASL volume in CF. Although we did not measure
the amiloride-sensitive PD after ASL volume challenges in CF
bronchiolar cultures, the abnormally low volume in CF suggests
that Na transport was not normally regulated (i.e., inhibited)
by low ASL volume in CF bronchioles. These data lead us to
speculate that failure to regulate Na transport with volume,
perhaps more than accelerated Na transport, is a key defect in
CF pathogenesis.
In addition to Na absorption, the epithelial cells in large
airways also have the capacity to secrete Cl when ENaC is
blocked and the appropriate Cl secretory driving forces are
generated (5). Cl secretion can be stimulated by agents that
increase the intracellular concentration of cAMP, presumably
through activation of CFTR, and by agents that increase the
intracellular activity of Ca2 and activate Ca2-dependent Cl
channels. Forskolin (cAMP)-dependent Cl secretion was ob-
served in non-CF small airways (21). Interestingly, addition of
the CFTR inhibitor DPC to non-CF bronchioles decreased the
residual Isc in the presence of amiloride, suggesting that CFTR-
dependent Cl secretion is revealed when Na absorption is
inhibited. Forskolin failed to increase Isc significantly in the pres-
ence of amiloride in CF bronchiolar cultures. In addition, the
residual Isc after addition of amiloride was significantly lower in
CF than in non-CF preparations, which likely reflects failure
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to initiate Cl secretion. The absence of cAMP-regulated Cl
secretion was expected because defective function of CFTR Cl
channel activity is the hallmark of CF, and this defect has been
reported in all epithelia in organs clinically affected by the dis-
ease, including the large airways.
In addition to the defect in cAMP-regulated Cl secretion,
we observed differences in ATP-activated Cl secretion in CF
and non-CF bronchioles. In vivo and in vitro studies have demon-
strated that the application of the purinergic agonists ATP or
uridine 5triphosphate (UTP) to the apical surface of large air-
ways stimulated Cl secretion to a similar or higher extent in CF
compared with non-CF airways (43–45). Several hypotheses have
been raised to explain this observation. For instance, CFTR might
attenuate Ca2-dependent Cl channel responses in normal tissues
by reducing the driving force for Cl exit across the luminal
membrane of airway epithelial cells (46). Recently, Ribeiro and
coworkers provided evidence that, in CF bronchial epithelium,
the mechanism for the larger intracellular Ca2 signals elicited
by activation of the apical purinergic receptors (P2Y2) is an
expansion of the apical endoplasmic reticulum Ca2 stores trig-
gered by chronic luminal airway infection or inflammation (47).
The cause of the decreased response to ATP in our CF bronchio-
lar preparations compared with their non-CF counterparts re-
mains to be determined. It has been suggested that the increased
purinergic agonist-mediated Cl secretion may counterbalance
the lack of inducible cAMP-dependent Cl secretion in CF large
airways (44, 45). This compensatory mechanism, if confirmed,
may be limited in small airways, which could aggravate the defect
in transepithelial Cl secretion and contribute to the severity
and precocity of the CF disease in small airways.
To relate the measurements of transepithelial ion transport
to fluid transport, we measured the ASL height in primary cul-
tures of non-CF and CF bronchiolar epithelial cells using confo-
cal microscopy. In bronchiolar preparations, the decrease in ASL
height after addition of an excess volume of fluid was faster in
CF compared with non-CF preparations and the resulting ASL
height was significantly lower in CF preparations. These data
indicate that CF bronchioles absorb fluid more rapidly than non-
CF bronchioles, and CF bronchioles cannot regulate ASL to
maintain sufficient volume for efficient mucus transport. In this
respect, bronchioles are similar to bronchi: using confocal mi-
croscopy, Tarran and coworkers measured the ASL height in
primary cultures of human non-CF and CF bronchial epithelial
cells (42). They found that 24 h after addition of an excess volume
of fluid on the cultures, the ASL height was approximately
7 m in normal cultures and 3 m in CF cultures (42). We found
similar results in bronchiolar preparations. In CF bronchi, the
increased absorption of ASL results from both increased (unreg-
ulated) Na absorption and defective CFTR-dependent Cl se-
cretion (6, 42). In CF bronchioles, our results suggest that the
increased absorption of ASL results from unregulated Na ab-
sorption in the face of decreased cAMP-activated Cl secretion.
Their results strengthen the current theory on the pathogenesis
of CF lung disease (i.e., ASL depletion leading to impaired
mucus clearance, which in turn favors recurrent bacterial infec-
tions and lung function deterioration), which until now was based
only on knowledge of ion and fluid transport in large airways.
Because a key difference between non-CF and CF small air-
ways was the defect in cAMP-activated Cl secretion, we as-
sessed the functional capacity of cAMP-activated Cl and fluid
secretions in non-CF large and small airways. To minimize any
variability due to differences in genetic background, age, smok-
ing status, and treatments, we obtained similarly processed pri-
mary cultures of bronchial and bronchiolar epithelial cells from
the same patients. The forskolin-induced increase in Isc was sig-
nificantly higher in bronchiolar than in bronchial cultures, sug-
gesting that the Cl secretion in response to cAMP was higher
in bronchioles. This difference in forskolin-dependent Isc in
the two airway regions was paralleled by differences in fluid
secretion. Confocal microscopy experiments revealed that bron-
chial and bronchiolar cultures displayed increased ASL height
in response to forskolin, reflecting fluid secretion. This increase
was significantly higher in bronchiolar compared with bronchial
cultures. Physiologically, one could argue that a greater Cl-
driven fluid secretion may compensate the lack of fluid-secreting
submucosal glands in small airways (48). The defective response
to forskolin in CF may have more severe consequences in terms
of fluid secretion in bronchioles compared with bronchi.
CONCLUSIONS
The data provide clues to differences in the ion and fluid trans-
port properties of large and small airways and add to knowledge
about physiologic similarities and differences between these two
airway regions. We found that the bioelectric properties of CF
bronchiolar epithelial cultures measured in Ussing chambers
differed from their non-CF counterparts in terms of Cl secretion
but not of the absolute rate of amiloride-sensitive Na absorp-
tion. The data from ASL volume measurements reveal low ASL
volume in CF, but not in normal bronchiolar cultures after a
volume challenge, likely reflecting unregulated (persistent) Na
absorption and defective CFTR-dependent Cl secretion. These
observations may have several implications for the understand-
ing of distal airways physiology: (1) the epithelia of large and
small normal airways share many similarities in terms of ion and
fluid transport but exhibit some differences with respect to the
magnitude of CFTR-regulated Cl and fluid secretion, (2) CFTR
defects result in ASL depletion in bronchiolar and bronchial
airway regions, and (3) CF bronchiolar defects reflect the ab-
sence of CFTR-mediated Cl secretion likely combined with
unregulated (persistent) Na absorption under these experimen-
tal conditions.
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